Pestano Linda 4
4 · Ensysce Biosciences, Inc. · Filed Feb 4, 2022
Insider Transaction Report
Form 4
Pestano Linda
Chief Development Officer
Transactions
- Award
Stock Option
2022-02-04+200,000→ 200,000 totalExercise: $2.48Exp: 2032-02-04→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]On February 4, 2022, Ms. Pestano was granted an option (the "Stock Option") to purchase 200,000 shares of common stock of Ensysce Biosciences, Inc. (the "Company"), par value $0.01 per share, with an exercise price of $2.48. The Stock Option is scheduled to vest over four years with 1/4 vesting upon the one year anniversary of October 15, 2021 and the remainder in equal installments monthly for the thirty-six months thereafter.